Letters & Testimony
CoPIRG Foundation letter to AQCC on cutting oil & gas pollution
Colorado's air quality regulators will consider a request this week to develop a new rule to cut more harmful pollution from oil and gas operations.
Groups warn of drug price increases with patent legislation
Senate Judiciary considers legislation that could increase drug prices
In anticipation of a vote in Senate Judiciary Committee on Sept 19, PIRG issued a strong letter opposing bills which could increase what patients pay for medication. Read the letter.
Letter to Congress: Support the Plastic Pellet Free Waters Act
Environment America, the Clean Water Network and Waterkeeper Alliance join more than 160 local, state and national clean water and environmental organizations in support of the Plastic Pellet Free Waters Act (S. 2337, H.R. 7634).
Junk fees should be banned, U.S. PIRG tells FTC
Companies should disclose the total price up front, including all mandatory fees, with accurate names for fees, what they're for and who they go to
I testified to Maine legislators in support of repair scores – LD 1716
Repair scores for tech such as laptops, phones, and appliances, are like EnergyGuide labels for repairability. They provide consumers with a 1 through 10 score that measures availability of spare parts, ease of disassembly, and longevity of support. This bill would cover cell phones, laptops, TVs, electric lawnmowers, top-loading washing machines, vacuum cleaners, and high-pressure washers for residential use by consumers.
PIRG joins open letter to Congress calling for “Same service, same price” policy
Patients shouldn’t be charged more for the same care simply because of where they receive it.
Hill Letter to US House: Vote “Yes” on Lower Costs, More Transparency
The Lower Costs, More Transparency Act will help lower health care costs for millions of Americans across the nation.
PIRG supports proposed FDA rule which will better protect patients from inaccurate lab tests
PIRG filed comments related to a rule proposed by the U.S. Food and Drug Administration (FDA) that would improve the accuracy and reliability of laboratory tests used to diagnose and treat patients across the United States.